Mr. Mark Capriani MBA
President and Chief Executive Officer, ACIES HEALTH INC
Member of the Healthcare Council
Council Member Biography
Mark Capriani, MBA, is the President and Chief Executive Officer of AciesHealth, a specialty pharmaceutical company in Pennsylvania. He has over 15 years of experience in pharmaceutical industry including biotech, branded and multi source pharmaceuticals, consumer products, device, and wound and burn care products. Mr. Capriani is an expert in the areas of cardiovascular, dermatology, diabetes, neurology, and pain management. He is also experienced in business development, managed care, marketing, and sales. Mr. Capriani has served as the President and Chief Executive Officer of Helix Pharmaceuticals, Inc. Prior to Helix, he has held various positions at Alpharma, Bertek, Elan, and Mylan Laboratories. (This is me - Update Profile)
Employment History
- 2005 - Unspecified
- President and Chief Executive Officer, ACIES HEALTH INC
- 2002 - 2005
- President and Chief Executive Officer, HELIX PHARMACEUTICALS
- 2000 - 2002
- Director, Elan Pharmaceuticals
GLG NewsSM Analyses by Mark Capriani(?)
Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
-
Recent Trends Give Xyzal Blockbuster Potential
May 30, 2007
FDA Approves XYZAL(R) (Levocetirizine Dihydrochloride) Tablets For The Relief Of Seasonal And Year Round Allergies, And Chronic Hives | www.medicalnewstoday.com
FDA approval for UCB / Sanofi-Aventis new prescription drug Xyzal for treatment of seasonal and perennial comes at the perfect time for a big win for the pharmaceutical companies. Xyzal has the potential to be the next blockbuster. The key questions: Will physicians embrace the new med; how will the product be marketed; and most importantly, how will managed care and patients react.
Leading institutions connect with Mark Capriani through GLG
GLG Study Groups with Mark Capriani(?)
| Study Group Name | No. Members |
|---|---|
| Experts in the Leisure & Lodging Council | 4887 |
| Experts in the Automotive Council | 3422 |
| Generic Drug Economic Experts | 766 |
| Economic Experts on Managed Care | 714 |
| Specialty Chemical Experts | 330 |
GLG Live Meetings with Mark Capriani(?)
Mark Capriani has not participated in any GLG Live Meetings.